Skip to main content
. Author manuscript; available in PMC: 2024 Feb 9.
Published in final edited form as: West J Nurs Res. 2022 Nov 4;45(4):344–362. doi: 10.1177/01939459221128125

Table 3.

Prevalence of Sickness Symptoms (N = 38).

Symptom Symptom Measures (Cutoff Score) Studies Using Symptom Measures Symptom Prevalence

Fatigue CIS (cutoff score of 35) Goedendorp et al. (2013) Severe fatigue 13%
van Sandwijk et al. (2019) Severe fatigue 33.3%
MFI-20 (cutoff score varying between 12 and 15 among fatigue dimensions) Chan et al. (2013) 59%
Chan et al. (2016) Physical fatigue 22%
MTSOSD-59R Du et al. (2021) 54.92%
FSI (cutoff score of 3) Rodrigue et al. (2011) Severe fatigue 59%
POMS (N/R) Tamura et al. (2018) 5.9%
POSs-renal (cutoff score of 1) Afshar et al. (2012) 55% (30% moderate to severe)
Fatigue presence (yes/no) Jordakieva et al. (2020) 55.4%
Depressive symptoms HADS (cutoff score of 5) Vásquez et al. (2013) 13.8%
HADS (cutoff score of 7) Barutcu Atas et al. (2021) 44.3
Gurkan et al. (2015) 25%
HADS (cutoff score of 8) Müller et al. (2015) 13.4%
Reber et al. (2016) 16.2%
van Sandwijk et al. (2019) 16.7%
Weng et al. (2013) 6.8%
Zhang et al. (2021) 5.9%
Zimmermann et al. (2016) 37.6%
HADS (cutoff score of 11) Jana et al. (2014) 8.57%
Klewitz et al. (2019) 9.6%
Scheel et al. (2018) 16.7%
BDI (cutoff score of 10) Anvar-Abnavi and Bazargani (2010) 75%
BDI (cutoff score of 11) Brito et al. (2019) 13.3%
BDI (N/R) Látos et al. (2016) 8.53%
BDI-PC (cutoff score of 4) Goedendorp et al. (2013) 13%
BDI-II (cutoff score: mild [>10], moderate [>15]) Robiner et al. (2021) BDI-II: mild 29%
Moderate 14%
MCMI-MD (base rate criteria of 75 or more) Robiner et al. (2021) 7%
SCL-90 Alavi et al. (2009) 39%
POSs-renal (cutoff score of 1) Afshar et al. (2012) 32%
BSI-18 (N/R) Jordakieva et al. (2020) 4.53%
DASS-21 (cutoff score of 10) Lai et al. (2020) 26.8%
POMS (cutoff t-score of 61) Tamura et al. (2018) 8.8%
MINI (N/A) Vásquez et al. (2013) 11.8%
PHQ-9 (cutoff score of 10) Zhang et al. (2019) 21.7%
Anxiety HADS (cutoff score of 8) Müller et al. (2015) 25%
Reber et al. (2016) 24.3%
Weng et al. (2013) 17.9%
Zhang et al. (2021) 7.6%
Zimmermann et al. (2016) 50.4%
HADS (cutoff score of 10) Barutcu Atas et al. (2021) 23.6%
Gurkan et al. (2015) 26.3%
HADS (cutoff score of 11) Jana et al. (2014) 8.57%
Klewitz et al. (2019) 12.2%
Scheel et al. (2018) 63.9%
BAI (cutoff score of 10) Brito et al. (2019) 20.3%
BAI (cutoff score of 16) Anvar-Abnavi and Bazargani (2010) 50%
SCL-90 (N/R) Alavi et al. (2009) 40.6%
POSs-renal (cutoff score of 1) Afshar et al. (2012) 36%
BSI-18 (N/R) Jordakieva et al. (2020) 4.03%
DASS-21 (cutoff score of 8) Lai et al. (2020) 41.1%
STAIS, STAIT (N/R) Látos et al. (2016) 4.26%
POMS (cutoff t-score of 61) Tamura et al. (2018) 4.4%
MINI (N/A) Vásquez et al. (2013) 15.1%

Note: BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory; BDI-PC, Beck Depression Inventory-Primary Care; BSI-18, Brief Symptoms Inventory-18 items; CIS, Checklist Individual Strength; DASS-21, Depression, Anxiety, and Stress Scale-21 items; FSI, Fatigue Symptom Inventory; HADS, Hospital Anxiety and Depression Scale; MFI-20, Multidimensional Fatigue Inventory-20 items; MCMI-MD, Millon Clinical Multiaxial Inventory III-Major Depression Scale; MINI, Mini-International Neuropsychiatric Interview; MTSOSD-59R, Modified Transplant Symptom Occurrence and Distress Scale-59 items Revised; N/A, not applicable; N/R, not reported; PHQ-9, Patient Health Questionnaire-9 items; POMS, Profile of Mood States; POSs-renal, Patient Outcome Scale symptom score-renal; SCL-90, Symptom Checklist-90 items; STAIS, Spielberger’s State and Trait Anxiety Scale-State; STAIT, Spielberger’s State and Trait Anxiety Scale-Trait.